Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BETCON: Conservative vs. Minimally Invasive vs. Surgical Treatment for MRONJ
NCT04512638Phase 4Recruiting
- Start
- Jan 2021
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in medication-related osteonecrosis of the jaw (MRONJ) (3 arms). Primary endpoint: Time to confirmed mucosal healing at 12 months. Started Jan 2021; status: recruiting.
02
Conditions
medication-related osteonecrosis of the jaw (MRONJ)
Beyond the preview
Go deeper on NCT04512638.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04512638.